Bright Minds Biosciences (DRUG) Stock Fundamentals

Bright Minds Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ian McDonald, with a market cap of $485.4M.

Market cap

$485.41M+24.1%

We’re still putting together Bright Minds Biosciences’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Bright Minds Biosciences up the queue, and we’ll analyze its filings next.

Earnings

Q2 2026 report

August 17, 2026

EPS-$0.17Beat by $1.05

Read the full report

Next report

Date not yet announced

Profile

CountryCanada

Listed2021

CEOIan McDonald

SectorHealthcare

IndustryBiotechnology

Websitebrightmindsbio.com

FilingsSEC EDGAR